CN1701072A - 用于治疗精神分裂症的杂环取代的哌嗪 - Google Patents

用于治疗精神分裂症的杂环取代的哌嗪 Download PDF

Info

Publication number
CN1701072A
CN1701072A CN 03825236 CN03825236A CN1701072A CN 1701072 A CN1701072 A CN 1701072A CN 03825236 CN03825236 CN 03825236 CN 03825236 A CN03825236 A CN 03825236A CN 1701072 A CN1701072 A CN 1701072A
Authority
CN
China
Prior art keywords
disease
quinoline
piperazine
dihydro
benzo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 03825236
Other languages
English (en)
Chinese (zh)
Inventor
汤加·L·安德雷纳
斯蒂芬·S·Y·乔
詹姆斯·M·格雷厄姆
特蕾西·F·格雷戈里
小哈里·R·霍华德
布赖恩·E·科恩伯格
沙姆·S·尼卡姆
德里克·A·弗卢姆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of CN1701072A publication Critical patent/CN1701072A/zh
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CN 03825236 2002-09-17 2003-09-05 用于治疗精神分裂症的杂环取代的哌嗪 Pending CN1701072A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41147502P 2002-09-17 2002-09-17
US60/411,475 2002-09-17
US60/416,355 2002-10-04

Publications (1)

Publication Number Publication Date
CN1701072A true CN1701072A (zh) 2005-11-23

Family

ID=35476681

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 03825236 Pending CN1701072A (zh) 2002-09-17 2003-09-05 用于治疗精神分裂症的杂环取代的哌嗪

Country Status (4)

Country Link
CN (1) CN1701072A (es)
CR (1) CR7735A (es)
TN (1) TNSN05074A1 (es)
ZA (1) ZA200502216B (es)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010012121A1 (zh) * 2008-07-28 2010-02-04 江苏国华投资有限公司 芳烷基哌啶（嗪）衍生物及其在治疗精神分裂症中的应用
CN102159557A (zh) * 2008-09-22 2011-08-17 弗·哈夫曼-拉罗切有限公司 哌嗪d3和5-ht2a受体调节剂
CN102718758A (zh) * 2011-03-31 2012-10-10 江苏恒谊药业有限公司 喹啉酮衍生物及其作为抗精神分裂症药物的应用
CN103130737A (zh) * 2011-12-05 2013-06-05 江苏恒谊药业有限公司 环己烷胺类化合物及其作为抗精神分裂症药物的应用
CN112142737A (zh) * 2019-06-29 2020-12-29 武汉珈瑜科技有限公司 一种治疗精神分裂症药物盐酸盐的固体形式
CN113727968A (zh) * 2019-05-14 2021-11-30 杏林制药株式会社 4-氧代吡咯烷-3-甲酰胺衍生物的制备方法

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010012121A1 (zh) * 2008-07-28 2010-02-04 江苏国华投资有限公司 芳烷基哌啶（嗪）衍生物及其在治疗精神分裂症中的应用
EP2322520A1 (en) * 2008-07-28 2011-05-18 Jiangsu Guohua Investment Co., Ltd Aralkyl substituted piperidine or piperazine derivatives and their use for treating schizophrenia
EP2322520A4 (en) * 2008-07-28 2012-04-25 Jiangsu Guohua Invest Co Ltd ARALKYL-SUBSTITUTED PIPERIDINE OR PIPERAZINE DERIVATIVES AND USES THEREOF FOR THE TREATMENT OF SCHIZOPHRENIA
US8653069B2 (en) 2008-07-28 2014-02-18 Jiangsu Hengyi Pharmaceutical Co., Ltd. Aralkyl substituted piperidine or piperazine derivatives and their use for treating schizophrenia
CN102159557A (zh) * 2008-09-22 2011-08-17 弗·哈夫曼-拉罗切有限公司 哌嗪d3和5-ht2a受体调节剂
CN102718758A (zh) * 2011-03-31 2012-10-10 江苏恒谊药业有限公司 喹啉酮衍生物及其作为抗精神分裂症药物的应用
CN103130737A (zh) * 2011-12-05 2013-06-05 江苏恒谊药业有限公司 环己烷胺类化合物及其作为抗精神分裂症药物的应用
CN103130737B (zh) * 2011-12-05 2015-12-02 江苏恒谊药业有限公司 环己烷胺类化合物及其作为抗精神分裂症药物的应用
CN113727968A (zh) * 2019-05-14 2021-11-30 杏林制药株式会社 4-氧代吡咯烷-3-甲酰胺衍生物的制备方法
CN113727968B (zh) * 2019-05-14 2024-08-23 杏林制药株式会社 4-氧代吡咯烷-3-甲酰胺衍生物的制备方法
CN112142737A (zh) * 2019-06-29 2020-12-29 武汉珈瑜科技有限公司 一种治疗精神分裂症药物盐酸盐的固体形式

Also Published As

Publication number Publication date
CR7735A (es) 2005-06-15
ZA200502216B (en) 2005-09-26
TNSN05074A1 (fr) 2007-05-14

Similar Documents

Publication Publication Date Title
CN1286815C (zh) 4－苯胺基喹啉－3－甲酰胺类化合物
CN1084747C (zh) 作为神经活性剂的吡咯并苯并氮杂䓬衍生物
CN1036920C (zh) 含杂环碳酸衍生物
CN1146566C (zh) 2-芳基-8-氧代二氢嘌呤衍生物及其制备方法、含该衍生物的药物组合物、及其中间体
CN1057083C (zh) 三环结构1－氨基乙基吡咯衍生物及其制备方法和用途
CN1262540C (zh) 二环类雄激素和孕甾酮受体调节化合物和方法
CN1370169A (zh) 取代的杂环稠合γ－咔啉
CN1169789C (zh) 用于治疗中枢神经系统疾病的氨基烷氧基咔唑
CN1161333C (zh) 作为生长激素释放剂的2-羟基吲哚衍生物
CN1061658C (zh) 三环苯并吖庚因加压素拮抗剂
CN1113236A (zh) 非肽基速激肽受体拮抗剂
CN1656075A (zh) 喹啉衍生物和其作为5－ht6配体的用途
CN1553909A (zh) 作为gaba受体配体的苯并咪唑和吡啶并咪唑衍生物
CN1031057C (zh) 制备三唑[4，3-a][1，4]苯并二氮杂䓬和噻吩并[3，2-f][1，2，4]三唑并[43-9][1，4]二氮杂䓬的方法
CN1934091A (zh) 治疗神经变性障碍的咪唑化合物
CN1378533A (zh) 苯氧基丙胺类化合物
CN1527827A (zh) 治疗性杂环化合物
CN1835944A (zh) 作为ccr－5拮抗剂的喹啉酰胺衍生物
CN1863789A (zh) 取代的异喹啉酮
CN1309561A (zh) 勃起机能障碍治疗剂
CN1812989A (zh) 用于治疗糖尿病和肥胖的5HT2c受体激动剂
CN1230962A (zh) 3－取代的吡啶并[4',3':4,5]噻吩并[2,3－d]嘧啶衍生物,它们的制备和应用
CN1268949A (zh) 稠合噻吩化合物及其医药用途
CN1437600A (zh) 作为抗病毒剂的吡咯并喹诺酮
CN1292697A (zh) 抗病毒化合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1080850

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1080850

Country of ref document: HK